Formosa Laboratories, Inc. — Investor Relations & Filings
Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告113年第一季合併財務報告董事會召開日期 | 2024-04-30 | Chinese | |
| 113年04月法人說明會簡報 — 474620240412E001.pdf | 2024-04-12 | Chinese | |
| 113年04月法人說明會簡報 — 474620240412M001.pdf | 2024-04-12 | Chinese | |
| 113年04月法人說明會簡報 | 2024-04-12 | Chinese | |
| 本公司受邀參加臺灣證交所與永豐金證券合作舉辦之113年「生技醫療產業」主題式業績發表會 | 2024-04-09 | Chinese | |
| 113年3月背書保證與資金貸與 | 2024-04-03 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 34617422 | 公告113年第一季合併財務報告董事會召開日期 | 2024-04-30 | Chinese | ||
| 34617431 | 113年04月法人說明會簡報 — 474620240412E001.pdf | 2024-04-12 | Chinese | ||
| 34617426 | 113年04月法人說明會簡報 — 474620240412M001.pdf | 2024-04-12 | Chinese | ||
| 34617423 | 113年04月法人說明會簡報 | 2024-04-12 | Chinese | ||
| 34617433 | 本公司受邀參加臺灣證交所與永豐金證券合作舉辦之113年「生技醫療產業」主題式業績發表會 | 2024-04-09 | Chinese | ||
| 34617437 | 113年3月背書保證與資金貸與 | 2024-04-03 | Chinese | ||
| 34617434 | 113年3月營業收入 | 2024-04-03 | Chinese | ||
| 34617439 | 113年03月內部人持股異動(事後) | 2024-04-03 | Chinese | ||
| 34617438 | 113年03月董事會成員及持股 | 2024-04-03 | Chinese | ||
| 34617441 | 112年度財務比率 | 2024-03-19 | Chinese | ||
| 34617442 | 112年第4季海外子公司投資 | 2024-03-19 | Chinese | ||
| 34617443 | 112年第4季大陸投資 | 2024-03-19 | Chinese | ||
| 34617445 | 董事會決議股利分派 | 2024-03-12 | Chinese | ||
| 34617447 | 112年度股利金額(董事會決議) | 2024-03-12 | Chinese | ||
| 34617449 | 本公司董事會決議召開113年股東常會 | 2024-03-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Formosa Laboratories, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52425/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52425 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52425 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52425 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52425}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Formosa Laboratories, Inc. (id: 52425)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.